Seguir
Alberto Indacochea
Alberto Indacochea
MD-PhD
Dirección de correo verificada de crg.eu
Título
Citado por
Citado por
Año
Analysis of racial/ethnic representation in select basic and applied cancer research studies
S Guerrero, A López-Cortés, A Indacochea, JM García-Cárdenas, ...
Scientific reports 8 (1), 13978, 2018
1352018
Analysis and implementation of an electronic laboratory notebook in a biomedical research institute
S Guerrero, G Dujardin, A Cabrera-Andrade, C Paz-y-Miño, A Indacochea, ...
PLoS One 11 (8), e0160428, 2016
302016
IDH mutation status trumps the Pignatti risk score as a prognostic marker in low-grade gliomas
O Etxaniz, C Carrato, I de Aguirre, C Queralt, A Muñoz, JL Ramirez, ...
Journal of neuro-oncology 135, 273-284, 2017
262017
Cold-inducible RNA binding protein promotes breast cancer cell malignancy by regulating Cystatin C levels
A Indacochea, S Guerrero, M Ureña, F Araujo, O Coll, ME LLeonart, ...
Rna 27 (2), 190-201, 2021
222021
Taxane-induced attenuation of the CXCR2/BCL-2 axis sensitizes prostate cancer to platinum-based treatment
VR de Porras, XC Wang, L Palomero, M Marin-Aguilera, C Solé-Blanch, ...
European urology 79 (6), 722-733, 2021
202021
UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept
J Martinez-Useros, T Georgiev-Hristov, MJ Fernández-Aceñero, ...
PLoS One 12 (8), e0182044, 2017
192017
A quick guide for using Microsoft OneNote as an electronic laboratory notebook
S Guerrero, A López-Cortés, JM García-Cárdenas, P Saa, A Indacochea, ...
PLoS computational biology 15 (5), e1006918, 2019
182019
Outcome prognostic factors in inoperable malignant bowel obstruction
M Romeo, M de los LLanos Gil, JL Cuadra Urteaga, L Vilà, S Ahlal, ...
Supportive Care in Cancer 24, 4577-4586, 2016
172016
In silico analyses reveal new putative Breast Cancer RNA-binding proteins
S Guerrero, A López-Cortés, JM García-Cárdenas, I Armendáriz-Castillo, ...
BioRxiv, 2020.01. 08.898965, 2020
122020
Melanoma RBPome identification reveals PDIA6 as an unconventional RNA-binding protein involved in metastasis
N Mestre-Farras, S Guerrero, N Bley, E Rivero, O Coll, E Borras, E Sabido, ...
Nucleic Acids Research 50 (14), 8207-8225, 2022
112022
Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker …
J García-Corbacho, A Indacochea, AE González Navarro, I Victoria, ...
Cancer Immunology, Immunotherapy 72 (6), 1709-1723, 2023
72023
Integrated in silico analyses identify PUF60 and SF3A3 as new spliceosome-related breast cancer RNA-binding proteins
JM García-Cárdenas, I Armendáriz-Castillo, A Pérez-Villa, A Indacochea, ...
Biology 11 (4), 481, 2022
42022
Prevalence of ROS1 translocation, HER2, and BRAF mutations in a cohort of advanced Non-Small Cell Lung Cancer (NSCLC) patients (p) triple negative (TN).
E Carcereny Costa, A Estival, LVÃ Martinez, MLGIL Gil Moreno, T Moran, ...
Journal of Clinical Oncology 33 (15_suppl), e22139-e22139, 2015
22015
Data mining identifies novel RNA-binding proteins involved in colon and rectal carcinomas
JM García-Cárdenas, I Armendáriz-Castillo, N García-Cárdenas, ...
Frontiers in Cell and Developmental Biology 11, 1088057, 2023
12023
125P Assessing the accuracy of multiple prognostic scores for immune checkpoint inhibitors (ICI) in patients with advanced solid tumors
J Garcia-Corbacho, A Indacochea, A Gonzalez, IV Ruiz, DM Fernández, ...
Annals of Oncology 33, S594-S595, 2022
12022
92P First-results of the CLIMB360 study, a prospective molecular screening program across multiple cancer types based on circulating tumor DNA (ctDNA)
J Garcia-Corbacho, IV Ruiz, L Angelats, A Indacochea, J Martínez-Vidal, ...
Annals of Oncology 32, S396-S397, 2021
12021
Genetic profiling across multiple cancer types using molecular prescreening comprehensive gene panels offered by clinical trials (CT).
I Victoria, D Moreno Fernandez, L Angelats, A Indacochea, F Pelegrín, ...
Journal of Clinical Oncology 39 (15_suppl), 3060-3060, 2021
12021
CSDE1 Intracellular Distribution as a Biomarker of Melanoma Prognosis
A Indacochea, T Guitart, A Boada, V Peg, A Quer, H Laayouni, L Condal, ...
International Journal of Molecular Sciences 25 (4), 2319, 2024
2024
1636P Circulating tumor DNA (ctDNA) profile in patients (pts) with pancreatic cancer (PC): A multicenter experience and challenges for clinical application
L Ghiglione, FJM i Carrillo, FM Esposito, DP Coronel, MD Delcuratolo, ...
Annals of Oncology 34, S905, 2023
2023
Unexpected Durable Complete Response With Anti–PD-L1 Blockade in Metastatic Undifferentiated Pleomorphic Sarcoma: A Case Report With Host and Tumor Biomarker Analysis
D Pesántez, A Indacochea, L Angelats, M Sirico, I Victoria, E Sanfeliu, ...
JCO Precision Oncology 7, e2300051, 2023
2023
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20